Mar 10 2010
Argon Medical Devices, Inc. announced today that it has entered into a definitive licensing agreement with privately held Rex Medical, LP ("Rex Medical") for exclusive rights to market and distribute the Cleaner™ Rotational Thrombectomy System in the United States, European Union and Canada. Cleaner is a medical device designed for the mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts.
Argon and Rex Medical will be exhibiting at the 34th Annual Meeting of the Society of Interventional
Radiology (SIR) to be held in Tampa, FL from March 14-17, 2008.
"We are excited to partner with Rex Medical on this innovative technology. Preserving dialysis access is one of the most challenging therapeutic issues within the vascular access arena. The launch of Cleaner will provide a fast, effective method for declotting occluded vessels and grafts," said George Leondis, President of Argon Medical. "This is a significant step forward in Argon's strategy to provide unique solutions to the interventional space, and we are confident this 'best in class' product will quickly become a leading technology in this fast-growing market segment."
SOURCE Argon Medical Devices, Inc.